Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
08/10/2011 | CN102145118A Morinda officinalis wine |
08/10/2011 | CN102145103A Traditional Chinese medicine composition for warming and invigorating kidney yang and replenishing qi to promote diuresis and preparation method thereof |
08/10/2011 | CN102145102A Traditional Chinese medicinal composition for warming and tonifying kidney yang and strengthening qi and promoting diuresis and preparation method thereof |
08/10/2011 | CN102145086A Plantago tonic decoction for treating chronic prostatitis |
08/10/2011 | CN102145040A Technique for adsorbing and extracting effective part of folium orthosiphoni by employing macroporous resin |
08/10/2011 | CN102145007A Finasteride soft capsule and amsulosin hydrochloride capsule compound preparation, used capsule and preparing method |
08/10/2011 | CN102145003A Medicinal composition containing insoluble medicament |
08/10/2011 | CN102144980A LHRH (luteinizing hormone-releasing hormone antagonist) lyophilized powder injection with improved stability |
08/10/2011 | CN101974068B Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof |
08/10/2011 | CN101843833B Chinese medicament for treating diabetic nephropathy |
08/10/2011 | CN101700370B Method for preparing pharmaceutical composition for treating diseases of urinary system and method for detecting components thereof |
08/10/2011 | CN101700367B Pharmaceutical composition for treating diseases of urinary system |
08/10/2011 | CN101690781B Traditional Chinese medicine composite for treating chronic nephritis |
08/10/2011 | CN101385768B Application of Loitered sheep root eluate in preparing drugs of chronic glomerulonephritis treatment |
08/09/2011 | US7994346 such as methyl 2-({(4S,5R)-5-[(1E,3E,7E)-(S)-10-(4-fluorophenoxy)-9-hydroxydeca-1,3,7-trien-5-yn-1-yl]-2,2-dimethyl-1,3-dioxolan-4-yl}methoxy)acetate, useful in treating inflammatory and autoimmune disorders in humans |
08/09/2011 | US7994317 sEH inhibitors and their use |
08/09/2011 | US7994282 Card proteins involved in cell death regulation |
08/09/2011 | US7994128 Conotoxin peptides useful as inhibitors of neuronal amine transporters |
08/09/2011 | US7993878 Antibodies to human IL-1β |
08/09/2011 | US7993849 Human TIMP-1 antibodies |
08/09/2011 | US7993671 Blend of: (a) one or more polymers; and (b) a drug that is liquid ad room temperature; free of water and other low boiling liquids; pressure-sensitive transdermal drug delivery system |
08/09/2011 | US7993643 Using low density lipoprotein receptor specific immunoglobulin for treatment and prevention of athersclerotic, kidney and inflammatory disorders |
08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
08/09/2011 | CA2441492C Rho-kinase inhibitors |
08/09/2011 | CA2428039C Serotonergic agents |
08/04/2011 | WO2011094208A2 Methods and pharmaceutical compositions for preventing and treating renal impairment |
08/04/2011 | WO2011093826A2 Effervescent formulations comprising cefaclor and clavulanic acid as active agents |
08/04/2011 | WO2011093825A2 Effervescent dosage forms comprising cephalosporin antibiotic |
08/04/2011 | WO2011093824A2 Effervescent formulations comprising cefaclor |
08/04/2011 | WO2011093823A2 Effervescent formulations comprising cefaclor and clavulanic acid |
08/04/2011 | WO2011092187A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
08/04/2011 | WO2011037913A3 Methods for preventing oxidative stress injury of a tissue by a folate-tempol conjugate |
08/04/2011 | US20110190355 Heterocyclic indazole derivatives |
08/04/2011 | US20110190341 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
08/04/2011 | US20110190340 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
08/04/2011 | US20110190319 Substituted heteroaryl fused derivatives as pi3k inhibitors |
08/04/2011 | US20110190308 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
08/04/2011 | US20110190294 Novel estrogen receptor ligands |
08/04/2011 | US20110190263 Compounds and compositions as modulators of gpr119 activity |
08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
08/04/2011 | US20110190240 Nuclear factor kappa b pathway inhibitor composition and use of same |
08/04/2011 | US20110189285 Hydrogel capable of containing and conveying cells |
08/04/2011 | US20110189121 Bitablets comprising compacted polyallylamine polymer and method for the production thereof |
08/04/2011 | US20110189082 Human gm-csf antigen binding proteins |
08/04/2011 | CA2784571A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
08/03/2011 | EP2351749A1 Carbamate compound or salt thereof |
08/03/2011 | EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
08/03/2011 | EP2351742A1 Indazole derivative |
08/03/2011 | EP2349996A1 1-phenylpyrrole compounds |
08/03/2011 | EP2349320A1 Compositions and methods for treatment of kidney disorders |
08/03/2011 | EP2349256A1 Heterocyclic benzimidazoles as trpm8 modulators |
08/03/2011 | EP2349239A1 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
08/03/2011 | EP1846366B1 Norvaline derivative and method for preparation thereof |
08/03/2011 | EP1480634B1 Selective androgen receptor modulators (SARMs) for treating benign prostate hyperplasia |
08/03/2011 | EP1446104B2 Spray drying methods |
08/03/2011 | CN102143956A Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof |
08/03/2011 | CN102143946A Calcium ion channel modulators & uses thereof |
08/03/2011 | CN102143740A Use of opioid antagonists for treating urinary retention |
08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
08/03/2011 | CN102140081A Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors |
08/03/2011 | CN102140064A Compounds for the treatment of metabolic disorders |
08/03/2011 | CN102139083A Formula of medicament for treating cholecystitis and urolithiasis |
08/03/2011 | CN102139019A Application of camellia oleifera peel extract |
08/03/2011 | CN102139017A Raw materials of kidney tonifying spirits, kidney tonifying spirits and preparation method of kidney tonifying spirits |
08/03/2011 | CN102139014A Traditional Chinese medicine for treating diabetic nephropathy |
08/03/2011 | CN102139013A Health care tonic wine for strengthening yang |
08/03/2011 | CN102139009A Traditional Chinese medicine for treating chronic prostatitis |
08/03/2011 | CN102139002A Cortex phellodendri polysaccharide extract and preparation method and medical application thereof |
08/03/2011 | CN102138992A Traditional Chinese medicine for treating benign prostatic hyperplasia |
08/03/2011 | CN102138981A Preparation method of plantago seed polysaccharide extractive and applications thereof |
08/03/2011 | CN102138954A Quality control method of pulean preparation |
08/03/2011 | CN102138932A Buffered compositions for dialysis |
08/03/2011 | CN102138919A New application of sodium ferrous chlorophyll to promotion of erythropoiesis |
08/03/2011 | CN102138900A Solid preparation of oxapium iodide liposome |
08/03/2011 | CN101919837B Application of rosmarinic acid in preparing medicament for treating or preventing renal fibrosis |
08/03/2011 | CN101766777B Chinese medicine composite for treating chronic renal failure |
08/03/2011 | CN101160287B 吡啶基非芳香族含氮杂环-1-羧酸酯衍生物 Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative |
08/02/2011 | US7989661 Human ADAM-10 inhibitors |
08/02/2011 | US7989654 High purity bases of 3,3-diphenylpropylamino monoesters |
08/02/2011 | US7989478 Cinnamoyl compound and use of the same |
08/02/2011 | CA2488242C Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
08/02/2011 | CA2470956C 1-alkyl-1-azoniabicyclo[2.2.2]octane carbamate derivatives and their use as muscarinic receptor antagonists |
08/02/2011 | CA2447632C Fusion protein agonist comprising a growth hormone binding portion and an external domain of a growth hormone receptor |
08/02/2011 | CA1341619C Recombinant inhibin |
07/28/2011 | WO2011090676A1 Compositions including pyruvate for companion animals and methods of use thereof |
07/28/2011 | WO2011089173A1 Hydrogel of microspheres |
07/28/2011 | WO2011068438A3 Agent for the treatment and prevention of diseases of the male urogenital system |
07/28/2011 | WO2011060065A3 Instillation of liposomal formulation of sirna and antisense oligonucleotides |
07/28/2011 | WO2010111599A3 Compositions and methods for treatment of renal disease |
07/28/2011 | US20110184038 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
07/28/2011 | US20110184032 Novel Phenylamino Isonicotinamide Compounds |
07/28/2011 | US20110184021 2-Acylaminopropoanol-Type Glucosylceramide Synthase Inhibitors |
07/28/2011 | US20110184015 Novel derivatives of pyrroloindole which are inhibitors of hsp90, compositions containing same, and use thereof |
07/28/2011 | US20110183997 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
07/28/2011 | US20110183991 5ht7 receptor ligands and compositions comprising the same |
07/28/2011 | US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
07/28/2011 | US20110183985 Substituted fused aryl and heteroaryl derivatives as pi3k inhibitors |
07/28/2011 | US20110183965 6-aminoisoquinoline compounds |